Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Clinical and Translational Science Research Department - Division of Interventional Radiology, Cisanello University Hospital, Bldg 30, Via Paradisa 2, 56124, Pisa, Italy.
Abdom Radiol (NY). 2022 Aug;47(8):2795-2810. doi: 10.1007/s00261-022-03555-9. Epub 2022 Jun 1.
Inflammatory pseudotumors of the liver (IPTL) are not exceptional benign lesions with various etiologies, histology, and imaging appearances. The incomplete knowledge of this pathology and the wide polymorphism sometimes resembling malignancy often induce long and expensive diagnostic flow, biopsy and occasionally unnecessary surgery. We propose a systematic revision of MRI literature data (2000-2021) with some narrative inserts and 10 new complete MRI cases, with the aim of organizing the data about IPTL and identifying some typical features able to improve its diagnosis from imaging.
We performed a systematic revision of literature from 2000 to 2021 to obtain MRI features, epidemiological, and clinical data of IPTL. The basic online search algorithm on the PubMed database was "(pseudotumor) AND (liver) AND (imaging)." Quality assessment was performed using both scales by Moola for case report studies and by Munn for cross-sectional studies reporting prevalence data. A case-based retrospective study by collecting patients diagnosed with IPTL from three different university hospitals from 2015 to 2021 was done as well. Only cases with MR examinations complete with T1/T2/contrast-enhanced T1/Diffusion-Weighted (W) images and pathology-proven IPTL were selected.
After screening/selection 38 articles were included for a total of 114 patients. In our experience we selected 10 cases for a total of 16 IPTLs; 8 out of 10 patients underwent at least 1 MRI follow-up. Some reproducible and rather typical imaging findings for IPTL were found. The targetoid aspect of IPTL is very frequent in our experience (75% on T1W, 44% on T2W, 81% on contrast-enhanced T1W (at least one phase), 100% on Diffusion-W images) but is also recurrent in the literature (6% on T1W, 31% on T2W, 51% on CE-T1W (at least one phase), 18% on Diffusion-W images, and 67% on hepatobiliary phase). In our experience, Apparent Diffusion Coefficient map values were always equal to or higher than those of the surrounding parenchyma, and at MRI follow-up, nodule/s disappeared at first/second control, in six patients, while in the remaining 2, lesions persisted with tendency to dehydration.
A targetoid-like aspect of a focal liver lesion must raise diagnostic suspicion, especially if IgG4-positive plasma is detected. MRI follow-up mainly shows the disappearance of the lesion or its reduction with dehydration.
肝脏炎性假瘤(IPTLS)是一种具有多种病因、组织学和影像学表现的非典型良性病变。由于对该病理学的认识不完整,以及广泛的多态性,有时类似于恶性肿瘤,这往往导致冗长和昂贵的诊断流程,包括活检和偶尔不必要的手术。我们提出了对 MRI 文献数据(2000-2021 年)进行系统复习,并结合一些叙述性插入和 10 个新的完整 MRI 病例,目的是整理关于 IPTL 的资料,并确定一些能够提高其影像学诊断的典型特征。
我们对 2000 年至 2021 年的文献进行了系统复习,以获得 IPTL 的 MRI 特征、流行病学和临床数据。在 PubMed 数据库上进行基本的在线搜索算法是 "(pseudotumor) AND (liver) AND (imaging)." 病例报告研究采用 Moola 量表和横断面研究采用 Munn 量表进行质量评估,报告患病率数据。还进行了一项基于病例的回顾性研究,从 2015 年至 2021 年,从三所不同的大学医院收集了诊断为 IPTL 的患者。仅选择了具有完整的 T1/T2/对比增强 T1/弥散加权(W)图像和经证实为 IPTL 的 MR 检查的病例。
经过筛选/选择,共纳入 38 篇文章,共 114 例患者。在我们的经验中,我们选择了 10 例共 16 例 IPTL;10 例患者中有 8 例至少进行了 1 次 MRI 随访。我们发现了一些可重复且相当典型的 IPTL 影像学表现。在我们的经验中,IPTLS 的靶样外观非常常见(T1W 上 75%,T2W 上 44%,对比增强 T1W 上至少 1 个相位上 81%,弥散加权图像上 100%),但在文献中也很常见(T1W 上 6%,T2W 上 31%,CE-T1W 上至少 1 个相位上 51%,弥散加权图像上 18%,肝胆相上 67%)。在我们的经验中,表观弥散系数图值始终等于或高于周围实质,在 MRI 随访中,在 6 例患者中,结节/首先/第二次消失,在其余 2 例中,病变随着脱水而持续存在。
肝脏局灶性病变的靶样外观必须引起诊断怀疑,尤其是在 IgG4 阳性血浆被检测到的情况下。MRI 随访主要显示病变消失或脱水后减少。